Product Information
DILTIAZEM 24H ER(LA) 120 MG TB is a generic product labeled by Slate Run Pharmaceuticals LLC, priced at $1.3699 per EA under NDC 70436019506. Its NADAC has been published 153 times since Jun 21, 2023.
FDA first approved this application on Mar 7, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
120 mg/1
Manufacturer
Slate Run Pharmaceuticals LLCNDC
70436019506
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
5/20/2026
Active Ingredients
DILTIAZEM HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA216439FDA Approved
3/7/2023
TE Code
AB
On Market Since
3/20/2023
Pharmacological Classes
Price Statistics
The NADAC for DILTIAZEM 24H ER(LA) 120 MG TB has been published 153 times since Jun 21, 2023, and over the history we have for it it has declined 39.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.3699 per EA |
|---|---|
| All-time high | $2.2648 (Oct 11, 2023) |
| All-time low | $1.0480 (May 22, 2024) |
| 52-week high | $1.7018 |
| 52-week low | $1.3036 |
| Median price | $1.4076 |
| Average price | $1.4872 |
| Largest weekly change | +30.5% (Jun 19, 2024) |
| Weeks tracked | 153 |
| Tracking since | Jun 21, 2023 |
1W
N/A
1M
N/A
3M
N/A
6M
-18.7%
1Y
+5.1%
3Y
-39.5%
5Y
N/A
All
-39.5%
Last surveyed May 20, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 93% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DILTIAZEM 24H ER(LA) 120 MG TB?
The current National Average Drug Acquisition Cost (NADAC) for DILTIAZEM 24H ER(LA) 120 MG TB, manufactured by Slate Run Pharmaceuticals LLC, is $1.3699 per EA (NDC 70436019506), effective May 20, 2026.
How has the price of DILTIAZEM 24H ER(LA) 120 MG TB changed over time?
Over the history we have for it, the NADAC for DILTIAZEM 24H ER(LA) 120 MG TB has declined 39.5%. It has been tracked across 153 weekly CMS publications since Jun 21, 2023.
What are the highest and lowest recorded NADAC prices for DILTIAZEM 24H ER(LA) 120 MG TB?
Since Jun 21, 2023, the NADAC for DILTIAZEM 24H ER(LA) 120 MG TB has ranged from a low of $1.0480 (May 22, 2024) to a high of $2.2648 (Oct 11, 2023), with a median of $1.4076 per EA.
Are there cheaper alternatives to DILTIAZEM 24H ER(LA) 120 MG TB?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DILTIAZEM 120 MG TABLET, is $0.0939 per EA — about 93% below DILTIAZEM 24H ER(LA) 120 MG TB.
Who manufactures DILTIAZEM 24H ER(LA) 120 MG TB?
DILTIAZEM 24H ER(LA) 120 MG TB (NDC 70436019506) is labeled by Slate Run Pharmaceuticals LLC, and CMS classifies it as a generic product.